Coston McIsaac & Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6K | Hold |
14
| – | – | ﹤0.01% | 598 |
|
|
2025
Q1 | $6K | Hold |
14
| – | – | ﹤0.01% | 577 |
|
|
2024
Q4 | $5K | Hold |
14
| – | – | ﹤0.01% | 591 |
|
|
2024
Q3 | $6 | Hold |
14
| – | – | ﹤0.01% | 583 |
|
|
2024
Q2 | $6K | Hold |
14
| – | – | ﹤0.01% | 549 |
|
|
2024
Q1 | $5K | Hold |
14
| – | – | ﹤0.01% | 579 |
|
|
2023
Q4 | $5K | Hold |
14
| – | – | ﹤0.01% | 573 |
|
|
2023
Q3 | $4K | Hold |
14
| – | – | ﹤0.01% | 593 |
|
|
2023
Q2 | $4K | Sell |
14
-7
| -33% | -$2K | ﹤0.01% | 638 |
|
|
2023
Q1 | $6K | Buy |
21
+7
| +50% | +$2K | ﹤0.01% | 570 |
|
|
2022
Q4 | $4 | Hold |
14
| – | – | ﹤0.01% | 629 |
|
|
2022
Q3 | $4K | Hold |
14
| – | – | ﹤0.01% | 541 |
|
|
2022
Q2 | $4K | Buy |
+14
| New | +$4K | ﹤0.01% | 380 |
|